Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Verification of separate measurement procedures where analytical determinations influence the clinical interpretation of GFR: Iohexol quantitation by HPLC and LC-MS/MS.

Schmit DJ, Carroll LJ, Eckfeldt JH, Seegmiller JC.

Clin Biochem. 2019 May;67:16-23. doi: 10.1016/j.clinbiochem.2019.03.007. Epub 2019 Mar 21.

PMID:
30905584
2.

Biological Variability of Estimated GFR and Albuminuria in CKD.

Waikar SS, Rebholz CM, Zheng Z, Hurwitz S, Hsu CY, Feldman HI, Xie D, Liu KD, Mifflin TE, Eckfeldt JH, Kimmel PL, Vasan RS, Bonventre JV, Inker LA, Coresh J; Chronic Kidney Disease Biomarkers Consortium Investigators.

Am J Kidney Dis. 2018 Oct;72(4):538-546. doi: 10.1053/j.ajkd.2018.04.023. Epub 2018 Jul 18.

PMID:
30031564
3.

Challenges in Measuring Glomerular Filtration Rate: A Clinical Laboratory Perspective.

Seegmiller JC, Eckfeldt JH, Lieske JC.

Adv Chronic Kidney Dis. 2018 Jan;25(1):84-92. doi: 10.1053/j.ackd.2017.10.006. Review.

PMID:
29499892
4.

Novel Filtration Markers for GFR Estimation.

Karger AB, Inker LA, Coresh J, Levey AS, Eckfeldt JH.

EJIFCC. 2017 Dec 19;28(4):277-288. eCollection 2017 Dec.

5.

Baseline Assessment of 25-Hydroxyvitamin D Reference Material and Proficiency Testing/External Quality Assurance Material Commutability: A Vitamin D Standardization Program Study.

Phinney KW, Sempos CT, Tai SS, Camara JE, Wise SA, Eckfeldt JH, Hoofnagle AN, Carter GD, Jones J, Myers GL, Durazo-Arvizu R, Miller WG, Bachmann LM, Young IS, Pettit J, Caldwell G, Liu A, Brooks SPJ, Sarafin K, Thamm M, Mensink GBM, Busch M, Rabenberg M, Cashman KD, Kiely M, Galvin K, Zhang JY, Kinsella M, Oh K, Lee SW, Jung CL, Cox L, Goldberg G, Guberg K, Meadows S, Prentice A, Tian L, Brannon PM, Lucas RM, Crump PM, Cavalier E, Merkel J, Betz JM.

J AOAC Int. 2017 Sep 1;100(5):1288-1293. doi: 10.5740/jaoacint.17-0291. Epub 2017 Aug 10.

PMID:
28797319
6.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2017 Oct;70(4):551-560. doi: 10.1053/j.ajkd.2017.04.025. Epub 2017 Jun 23.

7.

Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis.

Inker LA, Levey AS, Tighiouart H, Shafi T, Eckfeldt JH, Johnson C, Okparavero A, Post WS, Coresh J, Shlipak MG.

Nephrol Dial Transplant. 2018 Mar 1;33(3):417-425. doi: 10.1093/ndt/gfx042.

8.

β-Trace Protein Assays: A Comparison Between Nephelometric and ELISA Methodologies.

White CA, Akbari A, Eckfeldt JH, Chakraborty D, McCudden C, Flemming JA, Lowe C, Labrecque P, Parent JL, Fergusson D, Gill JS, Knoll GA.

Am J Kidney Dis. 2017 Jun;69(6):866-868. doi: 10.1053/j.ajkd.2017.02.371. Epub 2017 Apr 12. No abstract available.

PMID:
28410764
9.

Estimating Glomerular Filtration Rate Using Serum Creatinine.

Levey AS, Eckfeldt JH.

Clin Chem. 2017 Jun;63(6):1161-1162. doi: 10.1373/clinchem.2016.262352. Epub 2017 Apr 5. Review. No abstract available.

10.

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

Inker LA, Coresh J, Sang Y, Hsu CY, Foster MC, Eckfeldt JH, Karger AB, Nelson RG, Liu X, Sarnak M, Appel LJ, Grams M, Xie D, Kimmel PL, Feldman H, Ramachandran V, Levey AS; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):69-78. doi: 10.2215/CJN.03660316. Epub 2016 Nov 10.

11.

Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.

Silvestre OM, Gonçalves A, Nadruz W Jr, Claggett B, Couper D, Eckfeldt JH, Pankow JS, Anker SD, Solomon SD.

Eur J Heart Fail. 2017 Mar;19(3):340-347. doi: 10.1002/ejhf.701. Epub 2016 Dec 14.

12.

Analytical and biological variability in biomarker measurement in the Hispanic Community Health Study/Study of Latinos.

Thyagarajan B, Howard AG, Durazo-Arvizu R, Eckfeldt JH, Gellman MD, Kim RS, Liu K, Mendez AJ, Penedo FJ, Talavera GA, Youngblood ME, Zhao L, Sotres-Alvarez D.

Clin Chim Acta. 2016 Dec 1;463:129-137. doi: 10.1016/j.cca.2016.10.019. Epub 2016 Oct 15.

13.

Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis.

Inker LA, Shafi T, Okparavero A, Tighiouart H, Eckfeldt JH, Katz R, Johnson WC, Dermond N, Tariq Z, Benayache I, Post WS, Coresh J, Levey AS, Shlipak MG.

Am J Kidney Dis. 2016 Nov;68(5):743-751. doi: 10.1053/j.ajkd.2016.06.021. Epub 2016 Aug 20.

PMID:
27555103
14.

Short-term Variability of Vitamin D-Related Biomarkers.

Lutsey PL, Parrinello CM, Misialek JR, Hoofnagle AN, Henderson CM, Laha TJ, Michos ED, Eckfeldt JH, Selvin E.

Clin Chem. 2016 Dec;62(12):1647-1653. Epub 2016 Sep 30.

15.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.

Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS; CRIC (Chronic Renal Insufficiency Cohort) Study Investigators.

Am J Kidney Dis. 2016 Dec;68(6):892-900. doi: 10.1053/j.ajkd.2016.07.021. Epub 2016 Sep 20.

16.

Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos.

Franceschini N, Deng Y, Flessner MF, Eckfeldt JH, Kramer HJ, Lash JP, Lee DJ, Melamed ML, Moncrieft AE, Ricardo AC, Rosas SE, Kaplan RC, Raij L, Cai J.

Nephrol Dial Transplant. 2016 Oct;31(10):1670-6. doi: 10.1093/ndt/gfw210. Epub 2016 Jun 2.

17.

Iterative Outlier Removal: A Method for Identifying Outliers in Laboratory Recalibration Studies.

Parrinello CM, Grams ME, Sang Y, Couper D, Wruck LM, Li D, Eckfeldt JH, Selvin E, Coresh J.

Clin Chem. 2016 Jul;62(7):966-72. doi: 10.1373/clinchem.2016.255216. Epub 2016 May 19.

18.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA; CKD Biomarker Consortium and the CRIC Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):68-76. doi: 10.1053/j.ajkd.2016.01.015. Epub 2016 Mar 3.

19.

In Reply.

Eckfeldt JH, Inker LA, Miller WG.

Arch Pathol Lab Med. 2016 Mar;140(3):207-8. doi: 10.5858/arpa.2015-0405-LE. No abstract available.

PMID:
26927712
20.

Estimating residual kidney function in dialysis patients without urine collection.

Shafi T, Michels WM, Levey AS, Inker LA, Dekker FW, Krediet RT, Hoekstra T, Schwartz GJ, Eckfeldt JH, Coresh J.

Kidney Int. 2016 May;89(5):1099-1110. doi: 10.1016/j.kint.2015.10.011. Epub 2016 Jan 21.

21.

The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.

Do AN, Lynch AI, Claas SA, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Tiwari HK, Arnett DK, Irvin MR.

J Hum Hypertens. 2016 Sep;30(9):549-54. doi: 10.1038/jhh.2015.121. Epub 2016 Jan 21.

22.

Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium.

Bis JC, Sitlani C, Irvin R, Avery CL, Smith AV, Sun F, Evans DS, Musani SK, Li X, Trompet S, Krijthe BP, Harris TB, Quibrera PM, Brody JA, Demissie S, Davis BR, Wiggins KL, Tranah GJ, Lange LA, Sotoodehnia N, Stott DJ, Franco OH, Launer LJ, Stürmer T, Taylor KD, Cupples LA, Eckfeldt JH, Smith NL, Liu Y, Wilson JG, Heckbert SR, Buckley BM, Ikram MA, Boerwinkle E, Chen YD, de Craen AJ, Uitterlinden AG, Rotter JI, Ford I, Hofman A, Sattar N, Slagboom PE, Westendorp RG, Gudnason V, Vasan RS, Lumley T, Cummings SR, Taylor HA Jr, Post W, Jukema JW, Stricker BH, Whitsel EA, Psaty BM, Arnett D.

PLoS One. 2015 Oct 30;10(10):e0140496. doi: 10.1371/journal.pone.0140496. eCollection 2015.

23.

Total Short-term Variability in Biomarkers of Hyperglycemia in Older Adults.

Parrinello CM, Lutsey PL, Couper D, Eckfeldt JH, Steffes MW, Coresh J, Selvin E.

Clin Chem. 2015 Dec;61(12):1540-1. doi: 10.1373/clinchem.2015.246231. Epub 2015 Oct 26. No abstract available.

24.

Biomarkers of Vitamin D Status and Risk of ESRD.

Rebholz CM, Grams ME, Lutsey PL, Hoofnagle AN, Misialek JR, Inker LA, Levey AS, Selvin E, Hsu CY, Kimmel PL, Vasan RS, Eckfeldt JH, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2016 Feb;67(2):235-42. doi: 10.1053/j.ajkd.2015.08.026. Epub 2015 Oct 23.

25.

Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D-Binding Protein in Blacks and Whites.

Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH, Hoofnagle AN.

Clin Chem. 2016 Jan;62(1):179-87. doi: 10.1373/clinchem.2015.244541. Epub 2015 Oct 9.

26.

Prevalence and Correlates of CKD in Hispanics/Latinos in the United States.

Ricardo AC, Flessner MF, Eckfeldt JH, Eggers PW, Franceschini N, Go AS, Gotman NM, Kramer HJ, Kusek JW, Loehr LR, Melamed ML, Peralta CA, Raij L, Rosas SE, Talavera GA, Lash JP.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1757-66. doi: 10.2215/CJN.02020215. Epub 2015 Sep 28.

27.

Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry.

Hoofnagle AN, Eckfeldt JH, Lutsey PL.

N Engl J Med. 2015 Oct 8;373(15):1480-2. doi: 10.1056/NEJMc1502602. Epub 2015 Sep 23. No abstract available.

28.

Using glomerular filtration rate estimating equations: clinical and laboratory considerations.

Levey AS, Eckfeldt JH.

Clin Chem. 2015 Oct;61(10):1226-9. doi: 10.1373/clinchem.2015.245282. Epub 2015 Aug 21. No abstract available.

29.

Heritability of telomere length in a study of long-lived families.

Honig LS, Kang MS, Cheng R, Eckfeldt JH, Thyagarajan B, Leiendecker-Foster C, Province MA, Sanders JL, Perls T, Christensen K, Lee JH, Mayeux R, Schupf N.

Neurobiol Aging. 2015 Oct;36(10):2785-90. doi: 10.1016/j.neurobiolaging.2015.06.017. Epub 2015 Jun 18.

30.

Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients.

Shafi T, Levey AS, Inker LA, Schwartz GJ, Knight C, Abraham AG, Eckfeldt JH, Coresh J.

Am J Kidney Dis. 2015 Oct;66(4):728-30. doi: 10.1053/j.ajkd.2015.06.010. Epub 2015 Jul 21. No abstract available.

31.

Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence.

Parrinello CM, Grams ME, Couper D, Ballantyne CM, Hoogeveen RC, Eckfeldt JH, Selvin E, Coresh J.

Clin Chem. 2015 Jul;61(7):938-47. doi: 10.1373/clinchem.2015.238873. Epub 2015 May 7.

32.

Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2014 CYS Survey.

Eckfeldt JH, Karger AB, Miller WG, Rynders GP, Inker LA.

Arch Pathol Lab Med. 2015 Jul;139(7):888-93. doi: 10.5858/arpa.2014-0427-CP. Epub 2015 Apr 17.

PMID:
25884370
33.

Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study.

Lutsey PL, Michos ED, Misialek JR, Pankow JS, Loehr L, Selvin E, Reis JP, Gross M, Eckfeldt JH, Folsom AR.

JACC Heart Fail. 2015 May;3(5):347-356. doi: 10.1016/j.jchf.2014.11.013. Epub 2015 Apr 8.

34.

Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.

Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG; CKD Biomarkers Consortium.

Am J Kidney Dis. 2015 Jul;66(1):75-83. doi: 10.1053/j.ajkd.2015.01.013. Epub 2015 Mar 12.

35.

Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium.

Hsu CY, Ballard S, Batlle D, Bonventre JV, Böttinger EP, Feldman HI, Klein JB, Coresh J, Eckfeldt JH, Inker LA, Kimmel PL, Kusek JW, Liu KD, Mauer M, Mifflin TE, Molitch ME, Nelsestuen GL, Rebholz CM, Rovin BH, Sabbisetti VS, Van Eyk JE, Vasan RS, Waikar SS, Whitehead KM, Nelson RG; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2015 May 7;10(5):894-902. doi: 10.2215/CJN.11541114. Epub 2015 Mar 4. Review.

36.

The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC).

Lutsey PL, Eckfeldt JH, Ogagarue ER, Folsom AR, Michos ED, Gross M.

Clin Chim Acta. 2015 Mar 10;442:75-81. doi: 10.1016/j.cca.2014.12.036. Epub 2015 Jan 9.

37.

The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study.

Do AN, Irvin MR, Lynch AI, Claas SA, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Tiwari HK, Limdi NA, Arnett DK.

Front Pharmacol. 2014 Sep 16;5:210. doi: 10.3389/fphar.2014.00210. eCollection 2014.

38.

Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study.

Alonso A, Misialek JR, Eckfeldt JH, Selvin E, Coresh J, Chen LY, Soliman EZ, Agarwal SK, Lutsey PL.

J Am Heart Assoc. 2014 Sep 18;3(5):e001082. doi: 10.1161/JAHA.114.001082.

39.

Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study.

Folsom AR, Alonso A, Misialek JR, Michos ED, Selvin E, Eckfeldt JH, Coresh J, Pankow JS, Lutsey PL.

Am Heart J. 2014 Sep;168(3):296-302. doi: 10.1016/j.ahj.2014.04.017. Epub 2014 Jun 9.

40.

Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study.

Sørensen IF, Vazquez AI, Irvin MR, Sørensen P, Davis BR, Ford CE, Boerwinkle E, Eckfeldt JH, Arnett DK.

Pharmacogenet Genomics. 2014 Nov;24(11):556-63. doi: 10.1097/FPC.0000000000000088.

41.

Serum fibroblast growth factor-23 is associated with incident kidney disease.

Rebholz CM, Grams ME, Coresh J, Selvin E, Inker LA, Levey AS, Kimmel PL, Vasan RS, Eckfeldt JH, Feldman HI, Hsu CY, Lutsey PL; Chronic Kidney Disease Biomarkers Consortium.

J Am Soc Nephrol. 2015 Jan;26(1):192-200. doi: 10.1681/ASN.2014020218. Epub 2014 Jul 24.

42.

Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.

Lutsey PL, Alonso A, Selvin E, Pankow JS, Michos ED, Agarwal SK, Loehr LR, Eckfeldt JH, Coresh J.

J Am Heart Assoc. 2014 Jun 10;3(3):e000936. doi: 10.1161/JAHA.114.000936.

43.

Cystatin C for glomerular filtration rate estimation: coming of age.

Levey AS, Fan L, Eckfeldt JH, Inker LA.

Clin Chem. 2014 Jul;60(7):916-9. doi: 10.1373/clinchem.2014.225383. Epub 2014 May 28. No abstract available.

44.

Comparison of cystatin C and creatinine-based equations for GFR estimation after living kidney donation.

Issa N, Kukla A, Jackson S, Riad SM, Foster MC, Matas AJ, Eckfeldt JH, Ibrahim HN.

Transplantation. 2014 Oct 27;98(8):871-7. doi: 10.1097/TP.0000000000000129.

PMID:
24825515
45.

Albumin adsorption onto surfaces of urine collection and analysis containers.

Robinson MK, Caudill SP, Koch DD, Ritchie J, Hortin G, Eckfeldt JH, Sandberg S, Williams D, Myers G, Miller WG.

Clin Chim Acta. 2014 Apr 20;431:40-5. doi: 10.1016/j.cca.2014.01.035. Epub 2014 Feb 7.

46.

Cystatin C enhances glomerular filtration rate estimating equations in kidney transplant recipients.

Kukla A, Issa N, Jackson S, Spong R, Foster MC, Matas AJ, Mauer MS, Eckfeldt JH, Ibrahim HN.

Am J Nephrol. 2014;39(1):59-65. doi: 10.1159/000357594. Epub 2014 Jan 18.

47.

Genome-wide association study identifies common loci influencing circulating glycated hemoglobin (HbA1c) levels in non-diabetic subjects: the Long Life Family Study (LLFS).

An P, Miljkovic I, Thyagarajan B, Kraja AT, Daw EW, Pankow JS, Selvin E, Kao WH, Maruthur NM, Nalls MA, Liu Y, Harris TB, Lee JH, Borecki IB, Christensen K, Eckfeldt JH, Mayeux R, Perls TT, Newman AB, Province MA.

Metabolism. 2014 Apr;63(4):461-8. doi: 10.1016/j.metabol.2013.11.018. Epub 2013 Dec 4.

48.

Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT.

Lynch AI, Irvin MR, Davis BR, Ford CE, Eckfeldt JH, Arnett DK.

Int J Hypertens. 2013;2013:578578. doi: 10.1155/2013/578578. Epub 2013 Oct 31.

49.

Theoretical foundations of the Study of Latino (SOL) Youth: implications for obesity and cardiometabolic risk.

Ayala GX, Carnethon M, Arredondo E, Delamater AM, Perreira K, Van Horn L, Himes JH, Eckfeldt JH, Bangdiwala SI, Santisteban DA, Isasi CR.

Ann Epidemiol. 2014 Jan;24(1):36-43. doi: 10.1016/j.annepidem.2013.10.011. Epub 2013 Oct 21.

50.

The Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth): design, objectives, and procedures.

Isasi CR, Carnethon MR, Ayala GX, Arredondo E, Bangdiwala SI, Daviglus ML, Delamater AM, Eckfeldt JH, Perreira K, Himes JH, Kaplan RC, Van Horn L.

Ann Epidemiol. 2014 Jan;24(1):29-35. doi: 10.1016/j.annepidem.2013.08.008. Epub 2013 Oct 9.

Supplemental Content

Loading ...
Support Center